Rethinking Optimal Therapy for Operable Pancreatic Cancer in the CASSANDRA Era.
0/5 보강
APA
Petrelli F, Dottorini L (2026). Rethinking Optimal Therapy for Operable Pancreatic Cancer in the CASSANDRA Era.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, JCO2502920. https://doi.org/10.1200/JCO-25-02920
MLA
Petrelli F, et al.. "Rethinking Optimal Therapy for Operable Pancreatic Cancer in the CASSANDRA Era.." Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026, pp. JCO2502920.
PMID
41779999 ↗
같은 제1저자의 인용 많은 논문 (5)
- Phase III placebo-controlled oncology trials in the last decade: evolution, methodological foundations, and clinical impact.
- State of the Art of Systemic Therapy in HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Scoping Review.
- Real-world evidence for 10 oncology drugs approved in the last 5 years: A comprehensive narrative synthesis.
- Subcutaneous Immunotherapy in Cancer: Where We Are Now, What It Changes, and What to Watch Next.
- Comparison of adjuvant and neoadjuvant therapies for muscle invasive bladder cancer: A network meta-analysis.